Literature DB >> 7973236

On closed test procedures for dose-response analysis.

D M Rom1, R J Costello, L T Connell.   

Abstract

This paper concerns the testing of a dose-response effect in medical studies. We consider two situations. The first is when the drug effect on a parameter of interest is likely to increase (or decrease) with increasing doses. We propose a procedure based on the closure principle of Peritz combined with an application of a closed testing procedure of Marcus et al. to a test proposed by Turkey et al. The second situation is the analysis of a drug effect where one might observe a reversal at higher doses. For this situation, we propose simultaneous examination of contrasts among the doses at each of several stages of the testing scheme. We calculate critical values for this procedure incorporating the correlation structure among the contrasts. Both procedures strongly control the family-wise error rate at the pre-determined alpha level. They also provide information about the shape of the dose response lacking in other commonly used procedures for testing against an ordered alternative hypothesis. We illustrate the procedures on two datasets.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7973236     DOI: 10.1002/sim.4780131509

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  4 in total

1.  A multicenter, randomized, double-blind, placebo-controlled, dose-finding trial of a long-acting formulation of octreotide in promoting weight loss in obese adults with insulin hypersecretion.

Authors:  R H Lustig; F Greenway; P Velasquez-Mieyer; D Heimburger; D Schumacher; D Smith; W Smith; N Soler; G Warsi; W Berg; J Maloney; J Benedetto; W Zhu; J Hohneker
Journal:  Int J Obes (Lond)       Date:  2006-02       Impact factor: 5.095

2.  Randomized clinical study of a histamine H3 receptor antagonist for the treatment of adults with attention-deficit hyperactivity disorder.

Authors:  Richard H Weisler; Gahan J Pandina; Ella J Daly; Kimberly Cooper; Cristiana Gassmann-Mayer
Journal:  CNS Drugs       Date:  2012-05-01       Impact factor: 5.749

3.  Triamcinolone versus inner-limiting membrane peeling in persistent diabetic macular edema (TIME study): design issues and implications.

Authors:  Antonia M Joussen; Claudia Weiss; Diana Bauer; Ralf-Dieter Hilgers
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-07-26       Impact factor: 3.117

4.  A non-parametric framework for estimating threshold limit values.

Authors:  Georgia Salanti; Kurt Ulm
Journal:  BMC Med Res Methodol       Date:  2005-11-07       Impact factor: 4.615

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.